Shanghai Bio-Heart Biological Technology Co., Ltd. Class H Financial Overview
Shanghai Bio-Heart Biological Technology Co., Ltd. Class H's market cap is currently HK$1.40B. The company's EPS TTM is HK$-0.12; its P/E ratio is -14.11; Shanghai Bio-Heart Biological Technology Co., Ltd. Class H is scheduled to report earnings on August 26, 2025, and the estimated EPS forecast is HK$―. See an overview of income statement, balance sheet, and cash flow financials.
